The following article is being retracted from publication in the journal Leukemia & Lymphoma:
Loic Ysaebert, Anne-Sophie Michallet, Julien Rossignol, and Bruno Cazin. Rituximab–cyclophosphamide–dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemia, July 2011;52(7):1401–1403. doi:10.3109/10428194.2011.591005
http://www.tandfonline.com/doi/abs/10.3109/10428194.2011.591005
We have been made aware that this article contains significant unattributed overlap with an article published in Leukemia:
J Rossignol, AS Michallet, L Oberic, M Picard, A Garon, C Willekens, R Dulery, X Leleu, B Cazin, and L Ysebaert. Rituximab–cyclophosphamide–dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia. doi:10.1038/leu.2010.27
This action constitutes a breach of ethics and of the warranties made by the authors to us. We note that we received, peer-reviewed, accepted, and published the article in good faith and based on these warranties, and censure the conduct of the authors.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘retracted'.
The Editors.